Rocket Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 6 | -$0.72 | -$0.72 | -$0.72 |
| Q2 2024 | 3 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2024 | 9 | -$0.79 | -$0.68 | -$0.74 |
| Q1 2025 | 5 | -$0.77 | -$0.68 | -$0.71 |
| Q2 2025 | 4 | -$0.71 | -$0.71 | -$0.71 |
| Q3 2025 | 4 | -$0.55 | -$0.55 | -$0.55 |
| Q4 2025 | 4 | -$0.62 | -$0.62 | -$0.62 |
| Q1 2026 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2026 | 3 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2026 | 3 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 3 | $0.13 | $0.13 | $0.13 |
Rocket Pharmaceuticals, Inc. Earnings Date And Information
Rocket Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.71 earnings per share for the quarter, topping analysts' consensus estimates of $-0.78 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Rocket Pharmaceuticals, Inc. has generated $-3 earnings per share over the last year ($-2.92 diluted earnings per share) and currently has a price-to-earnings ratio of -5.15. Rocket Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
Rocket Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.78 | -$0.71 | 0.07 | $564,309 | $0 |
| 08/06/2024 | Q2 2024 | -$0.74 | $1.84 M | $0 | ||
| 05/07/2024 | Q1 2024 | -$0.66 | $0 | |||
| 02/27/2024 | Q4 2023 | -$0.64 | $10.31 M | |||
| 11/07/2023 | Q3 2023 | -$0.75 | $0 | |||
| 08/09/2023 | Q2 2023 | -$0.82 | $0 | |||
| 05/05/2023 | Q1 2023 | -$0.69 | $0 | |||
| 02/28/2023 | Q4 2022 | -$0.88 | $0 | |||
| 11/04/2022 | Q3 2022 | -$0.86 | $0 | |||
| 08/09/2022 | Q2 2022 | -$0.83 | $0 | |||
| 05/06/2022 | Q1 2022 | -$0.67 | $0 | |||
| 02/28/2022 | Q4 2021 | -$0.69 | $0 | |||
| 11/05/2021 | Q3 2021 | -$0.79 | $0 | |||
| 08/09/2021 | Q2 2021 | -$0.66 | -$0.55 | 0.11 | $0 | |
| 05/10/2021 | Q1 2021 | -$0.77 | -$0.65 | 0.12 | $0 | |
| 03/01/2021 | Q4 2020 | -$1.10 | $0 | |||
| 11/06/2020 | Q3 2020 | -$0.53 | $0 | |||
| 08/05/2020 | Q2 2020 | -$0.51 | -$0.45 | 0.06 | $0 | |
| 05/08/2020 | Q1 2020 | -$0.45 | $0 | |||
| 03/06/2020 | Q4 2019 | -$0.36 | $0 |
Rocket Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Rocket Pharmaceuticals, Inc.'s earnings date?
Rocket Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
-
Did Rocket Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Rocket Pharmaceuticals, Inc. (:RCKT) reported $-0.71 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.78 by $0.07.
-
How can I listen to Rocket Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Rocket Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Rocket Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Rocket Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Rocket Pharmaceuticals, Inc. generate each year?
Rocket Pharmaceuticals, Inc. (:RCKT) has a recorded net income of $0. Rocket Pharmaceuticals, Inc. has generated $-2.92 earnings per share over the last four quarters.
-
What is Rocket Pharmaceuticals, Inc.'s price-to-earnings ratio?
Rocket Pharmaceuticals, Inc. (:RCKT) has a price-to-earnings ratio of -5.15 and price/earnings-to-growth ratio is -3.59.
